Belite Bio Inc

BLTE | NASDAQ

Price Alert Chart Builder DCF Calculator

$173.40

+$2.44 (+1.43%)

At close: Sep 21, 2026, 4:00 PM ET

$174.50

+$1.10 (+0.63%)

Pre-market: Sep 22, 2026, 9:11 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $6.95B

Enterprise Value $6.95B

Beta -1.24

Average Volume 194.87K

Shares Outstanding (Diluted) 40.18M

Shares Change YoY 23.32%

Institutional Ownership 22.87%

Exchange NASDAQ

ISIN US07782B1044

Price Performance

Price Change 1M 7.7%

Price Change 3M 19.5%

Price Change 6M 11.8%

Price Change YTD 8.9%

Price Change 1Y 143.2%

Price Change 3Y 450.5%

Price Change 5Y 1537.4%

1M CAGR (ann.) 6.3%

1Y CAGR (ann.) 136.7%

5Y CAGR (ann.) N/A

All-Time CAGR 88.8%

Valuation

PE Ratio -62.83

Forward PE 71.02

PEG Ratio 1.24

Forward PEG 0.39

PS Ratio N/A

Forward PS 25.30

PB Ratio 8.73

P/FCF Ratio -658,028.47

P/Adj. FCF Ratio -140,470.37

P/OCF Ratio N/A

EV/Sales N/A

EV/EBIT -60.86

EV/EBITDA -60.86

EV/FCF -658,028.47

Earnings Yield -1.6%

FCF Yield 0.0%

Adj. FCF Yield 0.0%

Financial Health

Net Debt $0

Total Debt $0

Cash & Short-Term Investments $0

Total Assets $811.27M

Current Ratio 33.56

Quick Ratio 33.56

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score 269.61

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -368.4%

Returns

Return on Assets -12.9%

Return on Equity -15.7%

Return on Invested Capital -15.3%

Return on Capital Employed -15.3%

Return on Tangible Assets -12.9%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -41.5%

EPS CAGR 5Y -32.7%

EPS CAGR 10Y N/A

FCF CAGR 3Y -150.0%

FCF CAGR 5Y 62.2%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 6

EPS Growth Next 3Y 222.6%

Revenue Growth Next 3Y N/A

Earnings Date Nov 8, 2026

EPS Estimate (next Q) -$0.79

EPS Growth Est (next Q) 21.0%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $245.83

Price Target Upside 41.8%

Cash Flow

Operating Cash Flow $-10.39K

Free Cash Flow $-10.56K

Adj. Free Cash Flow $-49.48K

FCF Per Share $0

OCF Per Share $0

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-118.69M

EBITDA $-114.22M

Net Income $-102.36M

EPS (Diluted) -$2.76

Revenue / Employee N/A

Profit / Employee $-2.5M

Employees 41